The role of dialyzer membrane flux in bio-incompatibility

Hemodialysis International

Volumn 12, Issue SUPPL. 2, 2008, Pages

  Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Biocompatibility; Dialyzer; Membrane flux

Indexed keywords

BETA 2 MICROGLOBULIN; CELLULOSE; CUPROPHANE; POLYAMIDE;

ACUTE KIDNEY FAILURE; AMYLOIDOSIS; ARTIFICIAL KIDNEY; ATHEROGENESIS; BIOCOMPATIBILITY; CLINICAL PRACTICE; CONFERENCE PAPER; DIALYSIS MEMBRANE; EXTRACORPOREAL CIRCULATION; HEART DEATH; HEMODIALYSIS; HUMAN; HYPOXEMIA; INFECTION; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; MEMBRANE TRANSPORT; MUSCLE ATROPHY; NANOTECHNOLOGY; OLIGURIA; SURVIVAL; WATER QUALITY;

BIOCOMPATIBLE MATERIALS; CELLULOSE; GLYCOPROTEINS; HUMANS; KIDNEY FAILURE, ACUTE; LECTINS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 53349096953     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00321.x     Document Type: Conference Paper

References (31)

1. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. JAMA. 1968; 203:1135-1137.
2. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest. 1977; 59:879-888.
3. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977; 296:769-774.
4. Davenport A, Ahmad R. The effect of reuse of cuprophan dialysers on dialysis induced leukopenia and thrombocytopenia. Dial Transplant. 1988; 17:132-134.
5. Davenport A. Intradialytic complications during hemodialysis. Hemodial Int. 2006; 10:162-167.
6. Gueler F, Gwinner W, Schiborr C, et al. Biocompatibility parameters of different dialysis membranes assessed during systemic inflammation. Blood Purif. 2005; 23:196-202.
7. Schönermarck U, Dengler C, Ebeling F, Heydenreich M, Hillebrand GF, Samtleben W. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes. Clin Nephrol. 2006; 66:357-363.
8. Opatrný K Jr, Krouzzecký A, Polanská K, et al. Does an alteration of dialyzer design and geometry affect biocompatibility parameters? Hemodial Int. 2006; 10:201-208.
9. Kerr PG, Sutherland WH, de Jong S, Vaithalingham I, Williams SM, Walker RJ. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: A randomized, single-blinded, controlled clinical trial. Am J Kidney Dis. 2007; 49:533-539.
10. Lonnemann G, Novick D, Rubinstein M, Passlick-Deetjen J, Lang D, Dinarello CA. A switch to high-flux helixone membranes reverses suppressed interferon-gamma production in patients on low-flux dialysis. Blood Purif. 2003; 21:225-331.
11. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med. 1994; 331:1338-1342.
12. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet. 1994; 344:570-572.
13. Himmelfarb J, Tolkoff Rubin N, Chandran P, Parker RA, Wingard RL, Hakim R. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol. 1998; 9:257-266.
14. Kurtal H, von Herrath D, Schaefer K. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis? Artif Organs. 1995; 19:391-394.
15. Cosentino F, Chaff C, Piedmonte M. Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant. 1994; 9(Suppl 4):179-182.
16. Jörres A, Gahl GM, Dobis C, et al. Hemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial. International Multicentre Study Group. Lancet. 1999; 354:1337-1341.
17. Gastaldello K, Melot C, Kahn RJ, Vanherweghem JL, Vincent JL, Tielemans C. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant. 2000; 15:224-230.
18. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: A meta-analysis. Kidney Int. 2002; 62:1819-1823.
19. Alonso A, Lau J, Jaber B. Biocompatible hemodialysis membranes for acute renal failure (Review). Cochrane Database Syst Rev. 2008; 23:CD005283.
20. Davenport A, Bouman C, Kirpalani A, et al. Delivery of renal replacement therapy in acute kidney injury: What are the key issues? Clin J Am Soc Nephrol. 2008; 3:869-875.
21. Hakim RM, Held PJ, Stannard DC, et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int. 1996; 50:566-570.
22. Bloembergen WE, Hakim RM, Stannard DC, et al. Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis. 1999; 33:1-10.
23. Hakim RM, Wingard RL, Husni L, Parker RA, Parker TF III. The effect of membrane biocompatibility on plasma beta2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol. 1996; 7:472-478.
24. Koda Y, Nishi S, Miyazaki S, et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997; 52:1096-1101.
25. Parker TF III, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int. 1996; 49:551-556.
26. MacLeod A, Daly C, Khan I, et al. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease (Review). Cochrane Database Syst Rev. 2001; 3:CD003234.
27. Krane V, Krieter DH, Olschewski M, et al. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis. 2007; 49:267-275.
28. Delmez JA, Yan G, Bailey J, et al. Hemodialysis (HEMO) Study Group. Cerebrovascular disease in maintenance hemodialysis patients: Results of the HEMO Study. Am J Kidney Dis. 2006; 47:131-138.
29. Cheung AK, Rocco MV, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol. 2006; 17:546-555.
30. Schiffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001; 16:1863-1869.
31. Davenport A, Davison AM, Will EJ. Membrane biocompatibility: Effects on cardiovascular stability in patients on hemofiltration. Kidney Int. 1993; 41(Suppl):S230-S234.